The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension.,Nature medicine

当前位置： X-MOL 学术 › Nat Med › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The need for reporting guidelines for early phase dose-finding trials: Dose-Finding CONSORT Extension.
Nature medicine Pub Date : 2022-01-01 , DOI: 10.1038/s41591-021-01594-1
Christina Yap ₁ , Alun Bedding ₂ , Johann de Bono ₁ , Munyaradzi Dimairo ₃ , Aude Espinasse ₁ , Jeffry Evans ₄ , Sally Hopewell ₅ , Thomas Jaki _{6,

7} , Andrew Kightley ₈ , Shing Lee ₉ , Rong Liu ₁₀ , Adrian Mander ₁₁ , Olga Solovyeva ₁ , Christopher J Weir ₁₂

Affiliation

Clinical Trials and Statistics Unit, Institute of Cancer Research, Sutton, UK.
Roche, Welwyn Garden City, UK.
School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
University of Glasgow, Glasgow, UK.
University of Oxford, Oxford, UK.
Lancaster University, Lancaster, UK.
University of Cambridge, Cambridge, UK.
Patient and Public involvement partner, Lichfield, Staffordshire, UK.
Columbia University, New York, NY, USA.
Bristol Meyers Squibb, Berkeley Heights, New Jersey, USA.
Centre for Trials Research, Cardiff University, Cardiff, UK.
Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.

中文翻译：

早期剂量探索试验报告指南的必要性：剂量探索 CONSORT 扩展。

更新日期：2022-01-06

点击分享查看原文

点击收藏

全部期刊列表>>